GO: Biological Process Terms | No. of genes that overlap with our list | Associated q-value | No. of genes in cancer pathway | Association with cancer pathway |
---|---|---|---|---|
Regulation of Signal Transduction | 540 (21.5%) | 1.54E-29 | 56 | 2.06E-15 |
Cellular Development Process, Cell Differentiation | 633 (19.2%) | 2.16E-21 | 74 | 4.02E-23 |
Phosphate Containing Compound Metabolic Process | 653 (19.1%) | 2.16E-21 | 59 | 2.35E-14 |
Anatomical Structure Formation, Morphogenesis | 271 (22.7%) | 8.04E-17 | 34 | 1.72E-11 |
Neuron Development | 229 (23.9%) | 8.47E-17 | 29 | 1.57E-09 |
Actin Cytoskeleton Organization | 142 (27.6%) | 1.53E-15 | 13 | 1.46E-03 |
Regulation of Catalytic Activity | 411 (19.8%) | 3.30E-15 | 48 | 5.03E-15 |
Circulatory System Development | 199 (23.3%) | 1.67E-13 | 40 | 1.45E-19 |
Cell Junction Assembly | 70 (33.8%) | 3.87E-12 | 10 | 3.12E-04 |
Vasculature Development | 139 (24.9%) | 1.28E-11 | 28 | 1.27E-13 |
Regulation of Adhesion | 137 (24.7%) | 2.71E-11 | 25 | 1.46E-11 |
Regulation of Programmed Cell Death | 339 (19.3%) | 5.69E-11 | 48 | 2.25E-17 |
Protein Kinase Activity | 180 (22.0%) | 4.18E-10 | 30 | 3.16E-15 |
Response to External Stimulus | 142 (23.1%) | 1.83E-09 | 20 | 4.95E-07 |
Epithelium Development | 214 (20.5%) | 4.47E-09 | 46 | 1.07E-25 |
Response to Growth Factor | 151 (22.1%) | 9.85E-09 | 35 | 5.21E-19 |
Protein Modification Process | 526 (17.0%) | 5.44E-08 | 57 | 6.96E-17 |
Regulation of Developmental Process | 190 (19.6%) | 1.19E-06 | 36 | 7.49E-17 |
Regulation of Cell Growth | 71 (21.5%) | 4.62E-05 | 9 | 3.88E-03 |
Mesonephros Development | 27 (26.0%) | 3.82E-04 | 12 | 2.08E-10 |